Disclosure of investigators' recruitment performance in multicenter clinical trials: a further step for research transparency

Rafael Dal-Re*, David Moher, Christian Gluud, Shaun Treweek, Jacques Demotes-Mainard, Xavier Carne

*Corresponding author for this work

Research output: Contribution to journalEditorial

12 Citations (Scopus)
3 Downloads (Pure)

Abstract

Many clinical trials are terminated before reaching the sample size needed to test the trials' hypotheses owing to poor recruitment.
Registries, such as ClinicalTrials.gov, provide information on the main features of a multicenter clinical trial (MCT) to the general public.
Site investigators are key to the success of MCTs; however, information on their recruitment performance is not publicly available.
We propose that sponsors should disclose the recruitment targets of all site investigators on ClinicalTrials.gov before a trial starts as well as their final recruitment. Information on issues that could have affected recruitment should also be provided.
This information will be of interest to different stakeholders such as patient organizations, sponsors, and MCT networks.
Disclosing all site investigators' recruitment figures could prompt queries to the sponsor from the scientific community about regional subgroup analyses, to assess if ethnic or standard-of-care differences have an impact on treatment outcomes.
Original languageEnglish
Article numbere1001149
Number of pages4
JournalPLoS Medicine
Volume8
Issue number12
DOIs
Publication statusPublished - 27 Dec 2011

Keywords

  • research ethics committee
  • publication
  • clinicaltrials.gov
  • randomized controlled-trials
  • cancer trials
  • statement
  • registration
  • sample-size
  • journal-editors
  • protocols

Cite this

Disclosure of investigators' recruitment performance in multicenter clinical trials : a further step for research transparency. / Dal-Re, Rafael; Moher, David; Gluud, Christian; Treweek, Shaun; Demotes-Mainard, Jacques; Carne, Xavier.

In: PLoS Medicine, Vol. 8, No. 12, e1001149, 27.12.2011.

Research output: Contribution to journalEditorial

Dal-Re, Rafael ; Moher, David ; Gluud, Christian ; Treweek, Shaun ; Demotes-Mainard, Jacques ; Carne, Xavier. / Disclosure of investigators' recruitment performance in multicenter clinical trials : a further step for research transparency. In: PLoS Medicine. 2011 ; Vol. 8, No. 12.
@article{73239308c94d49c68b469b850c239b6b,
title = "Disclosure of investigators' recruitment performance in multicenter clinical trials: a further step for research transparency",
abstract = "Many clinical trials are terminated before reaching the sample size needed to test the trials' hypotheses owing to poor recruitment.Registries, such as ClinicalTrials.gov, provide information on the main features of a multicenter clinical trial (MCT) to the general public.Site investigators are key to the success of MCTs; however, information on their recruitment performance is not publicly available.We propose that sponsors should disclose the recruitment targets of all site investigators on ClinicalTrials.gov before a trial starts as well as their final recruitment. Information on issues that could have affected recruitment should also be provided.This information will be of interest to different stakeholders such as patient organizations, sponsors, and MCT networks.Disclosing all site investigators' recruitment figures could prompt queries to the sponsor from the scientific community about regional subgroup analyses, to assess if ethnic or standard-of-care differences have an impact on treatment outcomes.",
keywords = "research ethics committee, publication, clinicaltrials.gov, randomized controlled-trials, cancer trials, statement, registration, sample-size, journal-editors, protocols",
author = "Rafael Dal-Re and David Moher and Christian Gluud and Shaun Treweek and Jacques Demotes-Mainard and Xavier Carne",
year = "2011",
month = "12",
day = "27",
doi = "10.1371/journal.pmed.1001149",
language = "English",
volume = "8",
journal = "PLoS Medicine",
issn = "1549-1277",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Disclosure of investigators' recruitment performance in multicenter clinical trials

T2 - a further step for research transparency

AU - Dal-Re, Rafael

AU - Moher, David

AU - Gluud, Christian

AU - Treweek, Shaun

AU - Demotes-Mainard, Jacques

AU - Carne, Xavier

PY - 2011/12/27

Y1 - 2011/12/27

N2 - Many clinical trials are terminated before reaching the sample size needed to test the trials' hypotheses owing to poor recruitment.Registries, such as ClinicalTrials.gov, provide information on the main features of a multicenter clinical trial (MCT) to the general public.Site investigators are key to the success of MCTs; however, information on their recruitment performance is not publicly available.We propose that sponsors should disclose the recruitment targets of all site investigators on ClinicalTrials.gov before a trial starts as well as their final recruitment. Information on issues that could have affected recruitment should also be provided.This information will be of interest to different stakeholders such as patient organizations, sponsors, and MCT networks.Disclosing all site investigators' recruitment figures could prompt queries to the sponsor from the scientific community about regional subgroup analyses, to assess if ethnic or standard-of-care differences have an impact on treatment outcomes.

AB - Many clinical trials are terminated before reaching the sample size needed to test the trials' hypotheses owing to poor recruitment.Registries, such as ClinicalTrials.gov, provide information on the main features of a multicenter clinical trial (MCT) to the general public.Site investigators are key to the success of MCTs; however, information on their recruitment performance is not publicly available.We propose that sponsors should disclose the recruitment targets of all site investigators on ClinicalTrials.gov before a trial starts as well as their final recruitment. Information on issues that could have affected recruitment should also be provided.This information will be of interest to different stakeholders such as patient organizations, sponsors, and MCT networks.Disclosing all site investigators' recruitment figures could prompt queries to the sponsor from the scientific community about regional subgroup analyses, to assess if ethnic or standard-of-care differences have an impact on treatment outcomes.

KW - research ethics committee

KW - publication

KW - clinicaltrials.gov

KW - randomized controlled-trials

KW - cancer trials

KW - statement

KW - registration

KW - sample-size

KW - journal-editors

KW - protocols

U2 - 10.1371/journal.pmed.1001149

DO - 10.1371/journal.pmed.1001149

M3 - Editorial

VL - 8

JO - PLoS Medicine

JF - PLoS Medicine

SN - 1549-1277

IS - 12

M1 - e1001149

ER -